Study of Velcade® and Bone Formation in Patients With Relapsed/Refractory Multiple Myeloma
NCT00128921
·
clinicaltrials.gov ↗
PHASE2
Phase
TERMINATED
Status
18
Enrollment
OTHER
Sponsor class
Stopped
study terminated due to low accrual
Conditions
Multiple Myeloma
Interventions
DRUG:
VELCADE™
Sponsor
University of Arkansas